Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.5522 BGN
95.21 M BGN
1.87 B BGN
45.40 M
About SOPHARMA AD BGN1
Sector
CEO
Ognian Ivanov Donev
Headquarters
Sofia
Website
Founded
1933
ISIN
BG11SOSOBT18
FIGI
BBG00JHW2KL9
Sopharma AD engages in the provision of pharmaceutical business. Its operations include production and marketing of medical products, medicinal substances as well as dosage forms. It also involved in research, engineering, and implementation activities in the field of phytochemistry, chemistry, and pharmacy. The firm offers dermatological products, gastroenterological, as well as psychoneurological, antiallergic and others. The company was founded in 1933 and is headquartered in Sofia, Bulgaria.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0KWF is 4.2600 BGN — it has decreased by −0.23% in the past 24 hours. Watch SOPHARMA AD BGN1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange SOPHARMA AD BGN1 stocks are traded under the ticker 0KWF.
0KWF reached its all-time high on Jan 4, 2018 with the price of 4.2900 BGN, and its all-time low was 0.0010 BGN and was reached on Mar 9, 2018. View more price dynamics on 0KWF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Today SOPHARMA AD BGN1 has the market capitalization of 954.60 M, it has increased by 1.43% over the last week.
Yes, you can track SOPHARMA AD BGN1 financials in yearly and quarterly reports right on TradingView.
SOPHARMA AD BGN1 is going to release the next earnings report on Nov 29, 2024. Keep track of upcoming events with our Earnings Calendar.
0KWF net income for the last quarter is 16.14 M BGN, while the quarter before that showed 29.71 M BGN of net income which accounts for −45.66% change. Track more SOPHARMA AD BGN1 financial stats to get the full picture.
SOPHARMA AD BGN1 dividend yield was 17.31% in 2023, and payout ratio reached 135.90%. The year before the numbers were 13.45% and 102.49% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SOPHARMA AD BGN1 EBITDA is 124.55 M BGN, and current EBITDA margin is 8.05%. See more stats in SOPHARMA AD BGN1 financial statements.
Like other stocks, 0KWF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SOPHARMA AD BGN1 stock right from TradingView charts — choose your broker and connect to your account.